HP and Parkinson disease: It has been found that the up‐regulation of haptoglobin expression is associated with blood‐brain barrier dysfunction, which causes various pathological conditions, including Alzheimer's disease (AD) (Johnson et al., 1992), Parkinson's disease (PD), and Huntington's disease (HD) (Huang et al., 2011).